MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...
Researchers have developed a new AI system that improves lung cancer detection by analysing CT scans at both microscopic and ...
Discover how a new nanophotonic chip uses genetic markers and AI to detect diseases in minutes, potentially revolutionising ...
MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.
UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various liver conditions and organ abnormalities ...
Natera, Inc. (NASDAQ: NTRA) a global leader in cell-free DNA and precision medicine, today announced that 20 abstracts, ...
Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...
The expanded collaboration builds on the companies’ existing joint initiative by bringing to market enhanced capabilities of DeepHealth’s new AI-powered Breast Suite, including ProFound Pro and ...